MK

Manoj Kumar Singh

Active Director Director DIN 10449661
DIN 10449661 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Manoj Kumar Singh

Data last updated:

Manoj Kumar Singh is a Director at Laxina Pharma Private Limited (since 2024). The company operates in Pharma. Laxina Pharma Private Limited reported revenue of ₹1.62 Cr (FY 2025).

DIN 10449661
Primary Designation Director
Industry Pharma
First Appointment 02 Jan 2024
Oldest Company Age 2 yrs
Largest company Laxina Pharma Private Limited · ₹1.62 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Laxina Pharma Private Limited U47721MH2024PTC416532
Director02 Jan 20242024₹1.62 Cr (FY 2025)Active

Board colleagues of Manoj Kumar Singh

Directorship timeline

Open interactive timeline →
Laxina Pharma Private Limited
Premium access

Shareholding and investment profile for Manoj Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manoj Kumar Singh

Manoj Kumar Singh currently holds 1 directorship: Laxina Pharma Private Limited (Director, since 02 Jan 2024, revenue ₹1.62 Cr (FY 2025)).

Manoj Kumar Singh was first appointed on 02 Jan 2024 as Director at Laxina Pharma Private Limited.

The current boards of Manoj Kumar Singh's companies include Vipulkumar Bharatbhai Patel (Laxina Pharma Private Limited), Zaher Karim Prasla (Laxina Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available